RNase HII-C Inhibitors

Chemical inhibitors of RNase HII-C act through various mechanisms to impede its ability to process RNA-DNA hybrids. Aurintricarboxylic acid functions by chelating essential divalent metal ions such as Mg2+, which are critical for the catalytic activity of RNase HII-C. This chelation effectively renders the enzyme inactive as it cannot perform its cleavage function without these metal ions. Similarly, Foscarnet directly inhibits RNase HII-C by binding to its active site, mimicking the pyrophosphate moiety of the nucleotide substrate, and thus blocking the enzyme's ability to hydrolyze its substrates. Nucleoside analogues like Dideoxyadenosine, Dideoxycytidine, Dideoxyguanosine, Dideoxythymidine, Stavudine, Tenofovir, Zidovudine, and Didanosine act as chain terminators. They become incorporated into RNA and prevent the extension of the RNA strand, leading to an incomplete RNA-DNA hybrid that RNase HII-C cannot effectively bind or cleave. As the enzyme relies on the integrity of these hybrids for its function, the incorporation of these analogues inhibits RNase HII-C activity by preventing proper substrate formation.

Additionally, Edoxaban, though primarily known for its anticoagulant properties, can indirectly reduce the availability of nucleotides for DNA synthesis, thereby limiting the formation of RNA-DNA hybrids that are essential for RNase HII-C's activity. Ribavirin, on the other hand, can be incorporated into RNA and cause mutations that may lead to structural changes within the RNA-DNA hybrid, which would decrease the efficiency or accuracy of RNase HII-C during its cleavage process. The collective action of these inhibitors targets the fundamental aspects of RNase HII-C's function: substrate binding, catalysis, and substrate integrity, ensuring that the enzyme's ability to process RNA-DNA hybrids is effectively suppressed. Each inhibitor achieves this through a distinct interaction with either the enzyme or its intended substrates, thereby providing a comprehensive blockade of RNase HII-C's enzymatic activity.